Article
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer
31 Dec 2020
Abstract excerpt
Castration resistant prostate cancer (CRPC) continues to be androgen receptor (AR) driven. Inhibition of AR signaling in CRPC could be advanced using state-of-the-art biophysical and biochemical techniques. Structural characterization of AR and its complexes by cryo-electron microscopy would advance the development of N-terminal domain (NTD) and ligand-binding domain (LBD) antagonists. The structural basis of AR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
